Water-Free Cyclosporine Eye Drop, 0.1 Percent, Effective for Dry Eye
MONDAY, April 10, 2023 (HealthDay News) -- A water-free cyclosporine solution is effective for treating moderate-to-severe dry eye disease (DED), according to a study published online April 6 in JAMA Ophthalmology.
Esen K. Akpek, M.D., from Johns Hopkins University in Baltimore, and colleagues evaluated whether water-free cyclosporine eye drop, 0.1 percent, is effective in treating DED. The analysis included 834 study participants randomly assigned to twice-daily cyclosporine solution or vehicle for 29 days.
The researchers found that participants treated with cyclosporine solution had greater improvement in total corneal fluorescein staining (tCFS) than the vehicle group (−4.0 versus −3.6 grades) at day 29 (change [∆], −0.4; 95 percent confidence interval [CI], −0.8 to 0; P = 0.03). Treatment benefits in the dryness score from baseline were seen in both groups: −12.2 points for cyclosporine and −13.6 points for vehicle (∆ = 1.4; 95 percent CI, −1.8 to 4.6; P = 0.38). Clinically meaningful reductions of three grades or higher in tCFS were achieved by 71.6 percent in the cyclosporine group versus 59.7 percent in the vehicle group (∆ = 12.6 percent; 95 percent CI, 6.0 to 19.3 percent; P < 0.001). Compared with nonresponders, these responders showed greater improvement in symptoms at day 29, including dryness (∆ = −4.6; 95 percent CI, −8.0 to −1.2; P = 0.007) and blurred vision (Δ = −3.5; 95 percent CI, −6.6 to −4.0; P = 0.03).
"The rapid onset and magnitude of improvements on the corneal epithelial damage are potential differentiators to existing therapies," the authors write.
Several authors disclosed ties to Novaliq, which funded the study.
Editorial (subscription or payment may be required)
Related Posts
El tabaquismo en el embarazo se ha reducido en un tercio desde 2016
MARTES, 31 de enero de 2023 (HealthDay News) -- Buenas noticias para las futuras...
Smartphone Sleep Health App Cuts Insomnia Severity Scores
WEDNESDAY, Aug. 24, 2022 (HealthDay News) -- Use of the digital sleep health...
Rates of Severe COVID-19 Lower With Nirmatrelvir in ≥65s
THURSDAY, Aug. 25, 2022 (HealthDay News) -- For adults aged 65 years or older,...
Hearing Loss, Tinnitus Common After Neurotoxic Chemo for Cancer
TUESDAY, Aug. 2, 2022 (HealthDay News) -- Cancer survivors who received a...